Holding(s) in Company

RNS Number : 1395M
Shield Therapeutics PLC
09 January 2023
 

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB00BYV81293

Issuer Name

SHIELD THERAPEUTICS PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

An acquisition or disposal of voting rights; An event changing the breakdown of voting rights

3. Details of person subject to the notification obligation

Name

Jupiter Fund Management PLC

City of registered office (if applicable)

London

Country of registered office (if applicable)

United Kingdom

4. Details of the shareholder

Name

City of registered office

Country of registered office

Northern Trust



5. Date on which the threshold was crossed or reached

06-Jan-2023

6. Date on which Issuer notified

09-Jan-2023

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8.A)

% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer

Resulting situation on the date on which threshold was crossed or reached

6.700000

0.000000

6.700000

37146992

Position of previous notification (if applicable)

4.680000

0.000000

4.680000


8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)

Number of direct voting rights (DTR5.1)

Number of indirect voting rights (DTR5.2.1)

% of direct voting rights (DTR5.1)

% of indirect voting rights (DTR5.2.1)

GB00BYV81293


37146992


6.700000

Sub Total 8.A

37146992

6.700000%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument

Expiration date

Exercise/conversion period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

 





Sub Total 8.B1




8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument

Expiration date

Exercise/conversion period

Physical or cash settlement

Number of voting rights

% of voting rights

 






Sub Total 8.B2




9. Information in relation to the person subject to the notification obligation

2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)

Ultimate controlling person

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Jupiter Fund Management Plc ( Chain 1)


0.000000

0.000000

0.000000%

Jupiter Fund Management Plc ( Chain 1)

Jupiter Fund Management Group Limited

0.000000

0.000000

0.000000%

Jupiter Fund Management Plc ( Chain 1)

Jupiter Asset Management Group Limited

0.000000

0.000000

0.000000%

Jupiter Fund Management Plc ( Chain 1)

Knightsbridge Asset Management Limited

0.000000

0.000000

0.000000%

Jupiter Fund Management Plc ( Chain 1)

Jupiter Investment Management Group Limited

0.000000

0.000000

0.000000%

Jupiter Fund Management Plc ( Chain 1)

Jupiter Asset Management Limited

6.700000

0.000000

6.700000%

Jupiter Fund Management Plc (Chain 2)

Merian Global Investors Limited

0.000000

0.000000

0.000000%

Jupiter Fund Management Plc (Chain 2)

Merian Global Investors (Jersey) Limited

0.000000

0.000000

0.000000%

Jupiter Fund Management Plc (Chain 2)

Merian Global Investors (Finance) Limited

0.000000

0.000000

0.000000%

Jupiter Fund Management Plc (Chain 2)

Merian Global Investors Holdings Limited

0.000000

0.000000

0.000000%

Jupiter Fund Management Plc (Chain 2)

Jupiter Investment Management Limited

0.000000

0.000000

0.000000%

10. In case of proxy voting

Name of the proxy holder

 

The number and % of voting rights held

 

The date until which the voting rights will be held

 

11. Additional Information

 

12. Date of Completion

09.01.2023

13. Place Of Completion

London, UK

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLBLMATMTTMBMJ
UK 100

Latest directors dealings